Zepp Health Corporation
Headquartered in Hefei, China, and established in 2013, Zepp Health Corporation (known as Huami Corporation until its rebranding in February 2021) is a technology firm specializing in the creation, production, and sale of intelligent wearable devices. Operating predominantly within the People's Republic of China, the…
1D
-5.6%
1W
-18.8%
1M
-29.1%
6M
-81.5%
YTD
-88.8%
1Y
-94.4%
2Y
-15.9%
5Y
-91.4%
10Y
–
Next earnings date
04/11/2026 (in 18 days)
Volatility around earnings
~65% stronger price swings than usual
PRICE TARGET LOW
US$12.00
CONSENSUS
US$12.00
MEDIAN
US$12.00
PRICE TARGET HIGH
US$12.00
No current analyst ratings available.
P/E
-0.07
P/B
0.02
EV/EBITDA
-4.88
RETURN ON EQUITY
-6.2%
NET MARGIN
-17.8%
DEBT/EQUITY
1.33
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
100.0%
FLOAT SHARES
14,317,674
AVG. DAILY VOLUME (30D)
34,837
Yu Pengtao
Yu Pengtao
FAN Meihui
Deng Cheng
Deng Cheng
Zepp Health Corporation is a company in the Technology sector, Consumer Electronics industry, headquartered in Netherlands.
The CEO is Wang Huang, the company employs around 763 people.
The IPO was on 08/02/2018; the stock trades on NYSE under the ticker ZEPP.
The average price target is US$12.00, ranging from US$12.00 to US$12.00, with a median of US$12.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 04/11/2026.
Around past earnings, price swings were roughly 65% stronger than usual.
Yes. The last dividend was US$0.03 per share, ex-date 25/03/2022, paid on 15/04/2022.
The dividend yield is 0.0% (as of 30/06/2026).
Comparable stocks include Apple, NXP Semiconductors, Elastic, NVIDIA, Microsoft, Broadcom, SK hynix and Micron Technology.
Clicking "Analyze stock" lets five strategies assess Zepp Health against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.